In conclusion, our findings show that hepatic Wtap deletion enhances HCC progression by activating GRB2–ERK1/2-mediated signaling pathway dependent on the downregulation of proteasome-related genes, particularly Psmb4 and Psmb6. Here, WTAP is linked to hepatocellular carcinoma.